All News

Found 3,693 articles

• Sorrento Therapeutics, Inc. To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/6/2014

• Ambrx, Inc. Appoints Barry Greene To Board Of Directors

  2/5/2014

• Sorrento Therapeutics, Inc. Welcomes Daniel Levitt As A Director To Its Board

  2/3/2014

• ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2014 Financial Results And Provides Corporate Update

  1/31/2014

• Wilex AG Nosedives As Company Cuts 80 Percent Of Workers

  1/30/2014

• Senior Management Of Progenics Pharmaceuticals, Inc. To Webcast Discussion Of Phase 2 Data From Two Trials In Prostate Cancer

  1/29/2014

• Bay Area's Igenica, Inc. Brings In $14 Million In Additional Series C Funding

  1/28/2014

• Genmab A/S Hauls In $182 Million+ In Private Funding

  1/24/2014

• ImmunoGen, Inc. Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2014 Financial Results

  1/24/2014

• Seattle Genetics, Inc. Announces ADCETRIS® (Brentuximab Vedotin) Approval In Japan For The Treatment Of Relapsed Or Refractory Hodgkin Lymphoma And Anaplastic Large Cell Lymphoma

  1/17/2014

• Fabrus LLC Obtains Chimerasome Nanoparticle Technology

  1/13/2014

• Sorrento Therapeutics, Inc. To Present At The Biotech Showcase 2014 And The 7th Annual OneMed Forum SF2014 In San Francisco

  1/13/2014

• Zymeworks Wraps Up $15 Million Funding Round

  1/9/2014

• CytomX Therapeutics, Inc. and ImmunoGen, Inc. Announce Strategic Collaboration to Develop Probody-Drug Conjugates Against Cancer Targets

  1/9/2014

• Mersana Therapeutics, Inc. Earns Second Milestone Payment In Fleximer-ADC Collaboration With Endo Pharmaceuticals

  1/9/2014

• Sorrento Therapeutics, Inc. Welcomes William S. Marth As Chairman Of The Board Of Directors

  1/9/2014

• AbbVie Wagers Up To $280 Million On Seattle Genetics, Inc. Collaboration

  1/8/2014

• Sorrento Therapeutics, Inc. Appoints Amar Singh As Executive Vice President And Chief Business Officer

  1/8/2014

• Mersana Therapeutics, Inc. Appoints Donald A. Bergstrom, M.D., Ph.D., And Eva M. Jack To Executive Leadership Positions

  1/8/2014

• Sorrento Therapeutics, Inc. Completes Acquisition Of Concortis Biosystems

  12/20/2013